Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD
2.490
0.00 (0.00%)
Apr 16, 2026, 4:10 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Vms Investment - China & Vietnam | 7.93M | 8.94M | - | - | - | | | | | |
Vms Investment - China & Vietnam Growth | -11.26% | - | - | - | - | | | | | |
Vms Operational - Malaysia & Singapore | 44.81M | 33.23M | - | - | - | | | | | |
Vms Operational - Malaysia & Singapore Growth | 34.82% | - | - | - | - | | | | | |
Vms Operational - Australia | 40.53M | 37.34M | - | - | - | | | | | |
Vms Operational - Australia Growth | 8.57% | - | - | - | - | | | | | |
| 93.27M | 79.51M | - | - | - | | | | | |
| 17.31% | - | - | - | - | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 6.25M | 5.83M | 5.58M | | | | | |
| 7.33% | 4.33% | 14.31% | | | | | |
| 22.83M | 21.39M | 19.19M | | | | | |
| 6.71% | 11.48% | 13.79% | | | | | |
| 42.76M | 37.33M | 30.30M | | | | | |
| 14.53% | 23.22% | 45.80% | | | | | |
| 1.59M | 2.34M | 2.03M | | | | | |
| -31.92% | 14.95% | -48.58% | | | | | |
| 73.43M | 66.89M | 57.10M | | | | | |
| 9.78% | 17.14% | 22.85% | | | | | |
Source: S&P Global Market Intelligence.
